Mind Cure Receives Health Canada Approval For Sale Of Moonbeam Mushroom Products

Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its functional mushroom products to begin to be sold within the country. The company has seen its branded Moonbeam Mushrooms products issued Natural Product Numbers the agency, enabling for the sale of the products at retailers.

The authorizations put the product line ahead of many competitors within the supplement and nutrition space whom often skip the task of receiving Health Canada compliance. Having the approval from the agency will provide additional transparency to consumers, while providing evidence that the products are in fact considered natural supplements.

The Moonbeam Mushrooms product line consists of three offerings, each of which is offered in the form of powder and capsules. The products are focused on different functional mushrooms, including Lion’s Mane, Reishi, and Turkey Tail. Further, they have been marked as being non-GMO, vegan, organic, free of soy as well as gluten. New product offerings from the firm are currently being investigated as well, in the fields of nootropics, psychoactive products and psychedelic substances.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

A timeline for products to hit retailers was not provided.

Mind Cure Health last traded at $0.55 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Could Fall Further. Here’s What I’m Buying | Rick Rule

Newmont Crushed Q3. So Why Did the Stock Fall?

Governments Bet on Critical Minerals While Investors Panic | John Passalacqua – First Phosphate

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Mind Cure Announces new CTO, Geoff Belair

This morning Mind Cure Health Inc. (CSE: MCUR) announced the hiring of Geoff Belair as...

Thursday, October 15, 2020, 09:39:12 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure: Mental Health Focused Firm To Commence Trading Monday

Mind Cure Health (CSE: MCUR) is the latest issue to hit the Canadian Securities Exchange...

Sunday, September 20, 2020, 09:00:00 AM

Mind Cure Set To Launch Products Into Psychedelic Therapy Adaptogen Supplement Category

Mind Cure Health (CSE: MCUR) has completed the development of its first products. The company...

Tuesday, January 26, 2021, 08:43:59 AM

Mindcure Ends Fiscal Q1 2022 With $15.6 Million Cash & Cash Equivalents, $2.8 Million Net Loss

Mind Cure Health (CSE: MCUR) announced on Tuesday the financial results for the three months ended...

Wednesday, October 27, 2021, 10:41:00 AM